Harold Aubrey de Lavenu - Dec 31, 2018 Form 5 Insider Report for CEN BIOTECH INC (CENBF)

Role
Director
Signature
/s/ Harold Aubrey de Lavenu
Stock symbol
CENBF
Transactions as of
Dec 31, 2018
Transactions value $
-$274,611
Form type
5
Date filed
5/28/2021, 08:32 AM
Previous filing
May 28, 2021
Next filing
Jun 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CENBF Convertible note Other -$275K -172K -23.82% $1.60* 549K Nov 15, 2018 Common Stock 107K $1.60 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 15, 2018, $171,632 of a $200,000 convertible promissory note issued by the issuer on November 25, 2016 to the reporting person was repaid by the issuer to the reporting person thereby reducing the amount due under the note to $28,368 and accordingly reducing the number of common stock shares of the issuer issuable upon conversion of the promissory note from 125,000 shares of common stock by 107,270 shares of common stock to 17,730 shares of common stock.
F2 The convertible note matured on November 25, 2018, however, the ability to convert the note into shares did not expire on such maturity date.
F3 At December 31, 2018, the reporting person also held 33,321 shares of the issuer's common stock directly, and held convertible promissory notes convertible into 548,980 shares of the issuer's common stock.

Remarks:

The reporting person has served as a member of the board of directors of the issuer since July 2017 and was appointed to serve as a vice president of the issuer on April 2, 2021.